Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04248764
Other study ID # 2019-KAE-0372
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 10, 2021
Est. completion date March 14, 2023

Study information

Verified date March 2023
Source Izmir Katip Celebi University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Delayed onset muscle soreness (DOMS) is associated with the initiation of a new physical activity or a sudden increase in exercise volume and intensity. DOMS also occurs following eccentric exercises such as ballistic stretching, downhill running, weight training and plyometrics. DOMS might prevent performing sports and decreases the performance of professional or recreational athletes. Recently, different soft tissue mobilization applications (massage, foam roller) have been preferred by many athletes to prevent DOMS. However, there is no study comparing the effects of these techniques on DOMS. Therefore, the aim of the present study is to investigate the effects of different soft tissue mobilization practices on DOMS and sportive performance in recreational athletes. In order to achieve this goal, a total of 36 recreational athletes will be included and will be allocated to three groups as foam roller group (n=12), massage group (n=12) and control group (n=12). Demographic data, thermal camera measurements, fatigue level assessments, and performance measurements will be performed. All measurements will be carried out four times as before the application, immediately after the application, after 24 hours and after 48 hours.


Description:

After being invited to the study, the demographic data of all participants who agreed to participate in the study will be recorded on a structured form. Participants will be randomly divided into three groups: Massage application group, Foam Roller application group and Control group. Afterwards, thermal imaging, perceived fatigue and pain level, blood lactate level measurements, and vertical jump assessments will be done for the quadriceps femoris muscle. Then, the fatigue protocol will be applied for the quadriceps femoris muscle and five-minute applications will be made according to the groups in which they are randomly separated. Evaluations made in the first applications will be made immediately after the applications, 24 hours and 48 hours later, as the 2nd, 3rd and 4th measurements. The assessor will not know which group the participants are from.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date March 14, 2023
Est. primary completion date January 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - Performing recreational sports at least 1 and at most 3 times a week. Exclusion Criteria: - Any musculoskeletal, neurological or other serious health problems experienced in the past six months - Not willing to participate in the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Foam roller application
Following the fatigue protocol, foam roller application will be applied to the quadriceps femoris muscle for five minutes in the prone position.
Massage application
Following the fatigue protocol, sports massage will be applied to the quadriceps femoris muscle for five minutes.

Locations

Country Name City State
Turkey Izmir Katip Celebi University Izmir

Sponsors (1)

Lead Sponsor Collaborator
Izmir Katip Celebi University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Tissue Temperature Change Tissue temperature change will be assessed by using thermal camera imaging which is a non-invasive method. By determining the temperature differences in the tissues with the thermal camera, it will be determined in which regions the circulation increases or decreases. Four measurements will be performed as immediately before, immediately after, 24 hours and 48 hours later from fatigue protocol.
Primary Blood Lactate Level Change Lactate Edge will be used and the lactate levels will be measured from a drop of blood. Four measurements will be performed as immediately before, immediately after, 24 hours and 48 hours later from fatigue protocol.
Secondary Perceived Fatigue and Pain Level Changes By using a 0-100 millimeter visual analog scale (0: none, 100: maximum), the participants will determine the fatigue and pain levels. Higher scores indicate worse fatigue and pain. Four measurements will be performed as immediately before, immediately after, 24 hours and 48 hours later from fatigue protocol.
Secondary Change in Lower Extremity Anaerobic Performance Vertical jump test will be used to evaluate the lower extremity anaerobic performance. Four measurements will be performed as immediately before, immediately after, 24 hours and 48 hours later from fatigue protocol.
See also
  Status Clinical Trial Phase
Completed NCT04371237 - Accelerating Post-exercise Muscle Glycogen Resynthesis in Humans: Impact of Combined Nutrient Intake and Intermittent Pneumatic Compression or Heat Therapy N/A
Completed NCT04182295 - Does Placebo Information Affect the Trial Outcomes and Participant Blinding? N/A
Completed NCT06112899 - The Effects of Swedish Massage and Manual Lymph Drainage on Muscle Fatigue N/A
Completed NCT03961022 - Effects of ReWin(d) Supplementation on the Recovery of DOMS Induced by Acute Exercice Phase 2
Completed NCT02923102 - Effects of Recoverben® on Recovery After Exhaustive Exercise N/A
Completed NCT02945098 - Kinesio Taping in Muscle Damage Response Induced by Eccentric Exercise N/A
Completed NCT02271854 - A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness Phase 3
Completed NCT01825616 - Vitamin D2, Muscle Damage, NASCAR Pitcrew N/A
Completed NCT00745771 - Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness Phase 2
Completed NCT05037942 - The Effects of Restriction Pressure on Muscle Damage Responses to Blood Flow Restriction Exercise N/A
Completed NCT05276986 - Effects of Delayed Muscle Pain on Respiratory Muscle Function N/A
Completed NCT05100459 - The Effects of Whey Protein Supplements on Markers of Exercise-induced Muscle Damage in Resistance-trained Individuals N/A
Completed NCT05607212 - Lumbosacral Muscle Sensitivity & Pressure Pain Threshold After Kettlebell Swings N/A
Completed NCT04742244 - Lemon Verbena Extract Oxidative Stress and Muscle Damage N/A
Completed NCT06433856 - Neuromuscular Responses to Recovery Techniques N/A
Not yet recruiting NCT04872374 - Effects of Parmigiano Reggiano on Skeletal Muscle Damage in Older Adults N/A
Completed NCT05998603 - Pre-sleep Protein Supplementation and Load Carriage Recovery in British Army Recruits N/A
Completed NCT04677985 - Analgesic Induces Similar Upper and Lower Body Pain Pressure Threshold Increases N/A
Recruiting NCT03540602 - Polyphenol Rich Supplementation on Markers of Recovery From Intense Resistance Exercise Phase 1
Completed NCT05924139 - Omega-3 Fatty Acid Supplementation to Enhance Performance N/A